Neoadjuvant chemotherapy for bladder cancer: Two decades on

Neoadjuvant chemotherapy for bladder cancer: Two decades on

Saved in:

Bibliographic Details
Main Author:	Rishi Nayyar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-01-01
Series:	Indian Journal of Urology
Online Access:	https://journals.lww.com/10.4103/iju.iju_432_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

Role of gemcitabine and cisplatin as neoadjuvant chemotherapy in muscle invasive bladder cancer: Experience over the last decade
by: Sunny Goel, et al.
Published: (2019-07-01)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
by: Dalia Elsayed, et al.
Published: (2023-04-01)

Effects of Neoadjuvant Chemotherapy on Rates of Depression in Muscle Invasive Bladder Cancer
by: Matthew DeSanto, et al.
Published: (2024-07-01)

NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER
by: N. S. Nurgaliev, et al.
Published: (2016-10-01)

Real-world comparison of neoadjuvant chemoimmunotherapy and chemotherapy in muscle-invasive bladder cancer
by: Xinjia Ding, et al.
Published: (2025-05-01)

Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions
by: N. G. Cowan, et al.
Published: (2014-01-01)

Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer
by: Meritxell Pérez, et al.
Published: (2025-03-01)

Efficacy and immunological effects of neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer
by: GAO Zhiqiang, CHEN Tao, LIU Lei, SUN Chunshan, JI Yilong, TANG Hao
Published: (2025-04-01)

Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
by: Elizabeth A Guancial, et al.
Published: (2016-01-01)

Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade
by: Hao Luo, et al.
Published: (2022-01-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2007-03-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Cost-effectiveness of perioperative durvalumab plus neoadjuvant chemotherapy for muscle invasive bladder cancer in the United States
by: Caicong You, et al.
Published: (2025-07-01)

A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer
by: Chinna Babu Dracham, et al.
Published: (2022-07-01)

Muscle invasive bladder cancer treated with gemcitabine plus cisplatin as neoadjuvant chemotherapy during the second trimester of pregnancy
by: Takeshi Sasaki, et al.
Published: (2025-03-01)

Neoadjuvant immunotherapy driven bladder preservation for muscle invasive bladder cancer
by: Jiao Hu, et al.
Published: (2025-08-01)

Prediction of response to neoadjuvant chemotherapy in patients with muscle-invasive urothelial bladder cancer: role of immune-related gene expression
by: Hadeer Mahmoud, et al.
Published: (2025-07-01)

NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER
by: O. N. Churuksaeva, et al.
Published: (2016-02-01)

Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion following Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer: An Initial Experience
by: Tünkut Doğanca, et al.
Published: (2024-06-01)

Progress in Personalizing Chemotherapy for Bladder Cancer
by: James S. Chang, et al.
Published: (2012-01-01)

Complete regress of a low-differentiated recurrence of the bladder cancer as the answer on two cycles of neoadjuvant polychemotherapy
by: P. G. Yakovlev, et al.
Published: (2020-05-01)

Neoadjuvant chemotherapy in oral cancers: Selecting the right patients
by: S Vishak, et al.
Published: (2015-01-01)

Mechanisms of drug resistance to neoadjuvant chemotherapy in breast cancer
by: K. A. Aliev, et al.
Published: (2024-10-01)

Immediate results of neoadjuvant chemotherapy for resectable colon cancer
by: D. I. Azovsky, et al.
Published: (2025-03-01)

Diffusion-weighted MRI-Derived ADC and tumor volume as predictive imaging markers for neoadjuvant chemotherapy response in muscle-invasive bladder cancer
by: Abolfazl Razzaghdoust, et al.
Published: (2025-01-01)

Perioperative Blood Transfusion Is Associated with Worse Survival in Patients Undergoing Radical Cystectomy after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
by: Tessa Ladner, et al.
Published: (2024-06-01)

Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting
by: Sanjib Saha, et al.
Published: (2025-04-01)

Neoadjuvant treatment patterns and biomarker selection in muscle-invasive bladder cancer
by: Wei He, et al.
Published: (2025-07-01)

Resistance to neoadjuvant chemotherapy in breast cancers: a metabolic perspective
by: Manon Desgres, et al.
Published: (2025-08-01)

The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency
by: Wu Yunlong, et al.
Published: (2023-02-01)

Efficacy and safety of XELOX combined with neoadjuvant radiotherapy versus neoadjuvant chemotherapy in locally advanced gastric cancer
by: Shanshan Bu, et al.
Published: (2025-04-01)

Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
by: Upasana Baruah, et al.
Published: (2015-01-01)

FACTORS PREDICTING RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC CANCER
by: Emine Yıldırım, et al.
Published: (2022-01-01)

Treatment of cardiotoxicity in patients with invasive breast cancer during neoadjuvant chemotherapy
by: Grigorii A. Ignatenko, et al.
Published: (2024-09-01)

Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies
by: S. A. Kuznetsov, et al.
Published: (2015-09-01)

BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
by: A. R. Bosieva, et al.
Published: (2021-08-01)

RELATIONSHIP OF THE IMMUNOLOGICAL PARAMETRES WITH NEOADJUVANT CHEMOTHERAPY EFFECTIVENESS IN BREAST CANCER PATIENTS
by: Y. V. Kukharev, et al.
Published: (2016-02-01)

Magnetic resonance imaging in evaluation of efficiency of neoadjuvant chemotherapy of breast cancer
by: A. V. Komyahov, et al.
Published: (2015-12-01)